Episode 142 - Continuing vs. Withholding RAS inhibitors before Surgery

<p><a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1743909/open_sms">Send us a text</a></p><p>Welcome back Rounds Table Listeners! Today we have a solo episode with Dr. Mike Fralick. This week, he discusses a recent systematic review and meta-analysis that looks at continuing versus withholding RAS inhibitors before noncardiac surgery. Here we go!</p><ol><li><a href='https://www.bjaopen.org/article/S2772-6096(25)00029-2/fulltext'>Evaluating the risks and benefits of continuing versus withholding renin–angiotensin system inhibitors: a systematic review and meta-analysis with trial sequential analysis</a> (0:00 – 8:20).</li></ol><p>The Good Stuff (8:21 – 9:44):</p><ul><li><a href='https://notebooklm.google/'>NotebookLM</a></li></ul><p>Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods</p>